Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Three-year, Non-interventional, Prospective, Multicenter Study to Evaluate the Long- Term Effectiveness of Lanadelumab in Real-world Clinical Practice (ENABLE)

NCT04130191 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT04130191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04130191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Three-year, Non-interventional, Prospective, Multicenter Study to Evaluate the Long- Term Effectiveness of Lanadelumab in Real-world Clinical Practice (ENABLE)
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
December 11, 2019
Completion date
September 9, 2024
Enrollment
140 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema (hae)